中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Menu
Issue 12
Dec.  2018
Turn off MathJax
Article Contents
Abstract
References
Article Navigation >  Journal of Clinical Hepatology  > 2018  >  34(12): 2619-2623

Association between fatty liver disease and lacunar infarction

DOI: 10.3969/j.issn.1001-5256.2018.12.022
Research funding:

 

  • Published Date: 2018-12-20
    Abstract

  • Objective To investigate whether fatty liver disease is a risk factor for lacunar infarction. Methods A retrospective analysis was performed for the clinical data of 457 patients with lacunar infarction (lacunar infarction group) and 120 control patients, who were hospitalized in our hospital from 2007 to 2017, to analyze whether fatty liver disease is a risk factor for lacunar infarction. The chi-square test was used for comparison of categorical data between groups, and the t-test was used for comparison of continuous data between groups. Univariate and multivariate regression analyses were used to screen out the risk factors for lacunar infarction. Results The lacunar infarction group had a significantly higher incidence rate of fatty liver disease than the control group (60. 39% vs 39. 17%, χ2= 17. 379, P < 0. 001) .The multivariate regression analysis showed that after adjustment for age, sex, smoking, drinking, hypertension, and diabetes, fatty liver disease was an independent risk factor for lacunar infarction (odds ratio [OR]= 1. 96, 95% confidence interval [CI]: 1. 21-3. 02, P =0. 003) . There was a significant interaction between obesity and fatty liver disease (P = 0. 001) . Non-obese fatty liver disease was an independent risk factor for lacunar infarction (OR = 3. 29, 95% CI: 1. 55-7. 23, P < 0. 001) ; however, in the obese subgroup, obese fatty liver disease was not an independent risk factor for lacunar infarction (P = 0. 532) , Age (OR = 6. 67, 95% CI: 1. 98 ～ 121. 56, P < 0. 001) , hypertension (OR = 6. 38, 95% CI: 5. 12 ～ 12. 06, P < 0. 001) were independent risk factors for lacunar infarction. Conclusion Non-obese fatty liver disease is an independent risk factor for lacunar infarction.

     

    • FullText(HTML)
    • References(23)
  • [1] MOK V, KIM JS. Prevention and management of cerebral small vessel disease[J]. J Stroke, 2015, 17 (2) :111-122.
    [2] TAKAO M, KOTO A. Pathology of lacunar infarction[J]. Nippon Rinsho, 2006, 64 (Suppl 8) :134-138.
    [3] ARBOIX A, MARTI-VILALTA JL. Lacunar stroke[J]. Expert Rev Neurother, 2009, 9 (2) :179-196.
    [4] DEARBORN JL, SCHNEIDER AL, SHARRETT AR, et al. Obesity, insulin resistance, and incident small vessel disease on magnetic resonance imaging:Atherosclerosis risk in communities study[J].Stroke, 2015, 46 (11) :3131-3136.
    [5] LEE JE, SHIN DW, YUN JM, et al. Insulin resistance is a risk factor for silent lacunar infarction[J]. Stroke, 2016, 47 (12) :2938-2944.
    [6] WU JJ. Association between drinking and lacunar infarction[J].Mod J Integr Tradit Chin West Med, 2014, 23 (5) :542-543. (in Chinese) 吴建军.饮酒与腔隙性脑梗死的关系探讨[J].现代中西医结合杂志, 2014, 23 (5) :542-543.
    [7] SALAMONE F, BUGIANESI E. Nonalcoholic fatty liver disease:The hepatic trigger of the metabolic syndrome[J]. J Hepatol, 2010, 53 (6) :1146-1147.
    [8] WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies[J]. Lancet, 2004, 363 (9403) :157-163.
    [9] Writing Group of 2010 Chinese Guidelines for the Management of Hypertension. 2010 Chinese guidelines for the management of hypertension[J]. Chin J Cardiol, 2011, 39 (7) :579-616. (in Chinese) 中国高血压防治指南修订委员会.中国高血压防治指南2010[J].中华心血管病杂志, 2011, 39 (7) :579-616.
    [10] Chinese Society of Diabetes, Chinese Medical Association. Chinese guidelines for the prevention and treatment of type 2 diabetes (2013version) [J]. Chin J Diabetes, 2014, 6 (7) :447-498. (in Chinese) 中华医学会糖尿病学分会.中国2型糖尿病防治指南 (2013版) [J].中华糖尿病杂志, 2014, 6 (7) :447-498.
    [11] Joint committee for developing Chinese guidelines on prevention and treatment of dyslipidemia in adults. Chinese guidelines on prevention and treatment of dyslipidemia in adults[J]. Chin J Cardiol, 2007, 35 (5) :390-419. (in Chinese) 中国成人血脂异常防治指南制订联合委员会.中国成人血脂异常防治指南[J].中华心血管病杂志, 2007, 35 (5) :390-419.
    [12] YANG GH, MA JM, LIU N, et al. Smoking and passive smoking in Chinese, 2002[J]. Clin J Epidemiol, 2005, 26 (2) :77-83. (in Chinese) 杨功焕, 马杰民, 刘娜, 等.中国人群2002年吸烟和被动吸烟的现状调查[J].中华流行病学杂志, 2005, 26 (2) :77-83.
    [13] KWAK MS, KIM KW, SEO H, et al. Non-obese fatty liver disease is associated with lacunar infarct[J]. Liver Int, 2018, 38 (7) :1292-1299.
    [14] KIM SU, SONG D, HEO JH, et al. Liver fibrosis assessed with transient elastography is an independent risk factor for ischemic stroke[J]. Atherosclerosis, 2017, 260:156-162.
    [15] HAMAGUCHI M, KOJIMA T, TAKEDA N, et al. Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease[J].World J Gastroenterol, 2007, 13 (10) :1579-1584.
    [16] ADAMS LA, ANSTEE QM, TILG H, et al. Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases[J]. Gut, 2017, 66 (6) :1138-1153.
    [17] MOSHAYEDI H, AHRABI R, MARDANI A, et al. Association between non-alcoholic fatty liver disease and ischemic stroke[J].Iran J Neurol, 2014, 13 (3) :144-148.
    [18] YING I, SAPOSNIK G, VERMEULEN MJ, et al. Nonalcoholic fatty liver disease and acute ischemic stroke[J]. Epidemiology, 2011, 22 (1) :129-130.
    [19] CRUZ ACD, BUGIANESI E, GEORGE J, et al. 379 characteristics and long-term prognosis of lean patients with nonalcoholic fatty liver disease[J]. Gastroenterology, 2014, 146 (5 Suppl) :S-909.
    [20] HAMAGUCHI M, KOJIMA T, FUKUDA T, et al. Nonoverweight nonalcoholic fatty liver disease and incident cardiovascular disease:A post hoc analysis of a cohort study[J]. Medicine (Baltimore) , 2017, 96 (18) :e6712.
    [21] BYRNE CD, TARGHER G. Ectopic fat, insulin resistance, and nonalcoholic fatty liver disease:Implications for cardiovascular disease[J].Arterioscler Thromb Vasc Biol, 2014, 34 (6) :1155-1161.
    [22] LI JX, XU XJ, TANG Q, et al. The relation between carotid atherosclerosis and lacunar infarction in hypertensive patients[J]. Chin J Geriatr Heart Brain Vessel Dis, 2007, 9 (8) :538-540. (in Chinese) 李金贤, 徐新娟, 唐琪, 等.高血压患者颈动脉粥样硬化病变与腔隙性脑梗死的关系[J].中华老年心脑血管病杂志, 2007, 9 (8) :538-540.
    [23] ARBOIX A, BLANCO-ROJAS L, OLIVERES M, et al. Clinical characteristics of acute lacunar stroke in women:Emphasis on gender differences[J]. Acta Neurol Belg, 2014, 114 (2) :107-112.
    • Relative Articles

  • Relative Articles

    [1]Miao ZHANG, Lirong ZHANG, Lin LUO, Qiang CHEN. Influence of fatty liver on the severity of acute pancreatitis[J]. Journal of Clinical Hepatology, 2022, 38(7): 1595-1601. doi: 10.3969/j.issn.1001-5256.2022.07.025
    [2]Jiang DENG, Zhiyi HAN, Cailan XIAO, Yating SUN, Yajun JI, Li AO, Yonghong ZHANG, Xiaolan LU. Prevalence rate of non-obese fatty liver disease and related influencing factors[J]. Journal of Clinical Hepatology, 2021, 37(11): 2600-2604. doi: 10.3969/j.issn.1001-5256.2021.11.022
    [3]Qin YU, Chen CHEN, Qian XIA, Jin CHEN. A case of acute cerebral infarction with splenic rupture secondary to splenic infarction[J]. Journal of Clinical Hepatology, 2021, 37(10): 2417-2419. doi: 10.3969/j.issn.1001-5256.2021.10.033
    [4]Wang CaiBin, Su Yang. Risk factors for posthepatectomy liver failure and related prevention and treatment methods[J]. Journal of Clinical Hepatology, 2020, 36(9): 2119-2124. doi: 10.3969/j.issn.1001-5256.2020.09.048
    [5]Yao ChengZi, Feng Gong, Yu WenSi, Du Huan, Mi Man. Risk factors for the development and progression of nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2020, 36(2): 433-436. doi: 10.3969/j.issn.1001-5256.2020.02.044
    [6]Ren DanDan, Liu Na, Zhou LuLu, Zhang Nan, Li ChunXia, Dong Bing, Xu GuangHua. Risk factors for hepatitis B virus-related hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2020, 36(7): 1634-1638. doi: 10.3969/j.issn.1001-5256.2020.07.041
    [7]Shu YunRan, Li JunQi, Liu Qiong. Epidemiology of nonalcoholic fatty liver disease and related risk factors[J]. Journal of Clinical Hepatology, 2019, 35(9): 2085-2090. doi: 10.3969/j.issn.1001-5256.2019.09.045
    [8]Feng Gong, Mi Man, Li XuePing, He Na, Chen ZiJun, Niu ChunYan. The economic burden and risk factors in inflammatory bowel disease with nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2018, 34(12): 2702-2706. doi: 10.3969/j.issn.1001-5256.2018.12.042
    [9]Chen BiHua, Zhang Wei, Wu Pei, Huang Ying. Research advances in risk factors for primary biliary cirrhosis[J]. Journal of Clinical Hepatology, 2015, 31(12): 2088-2092. doi: 10.3969/j.issn.1001-5256.2015.12.024
    [10]Zhao HongXin, Yan Rong, Niu ChunYan, Zhou YongLi, Wang Jia, Cao RuiQi. Prevalence and associated risk factors for obesity and nonalcoholic fatty liver disease in adolescents in Xi′an, Shaanxi province, China[J]. Journal of Clinical Hepatology, 2015, 31(8): 1248-1251. doi: 10.3969/j.issn.1001-5256.2015.08.016
    [11]Qiao LiNa, Dai GuangRong, Zhang Jin, Shen Ni. An epidemiological survey of prevalence and risk factors for fatty liver disease in adults residing in Yan'an,China[J]. Journal of Clinical Hepatology, 2015, 31(1): 82-87. doi: 10.3969/j.issn.1001-5256.2015.01.018
    [12]Yu Zheng, Jia JiDong. Risk factors, diagnostic criteria, and drug discontinuation criteria for drug- induced liver injury[J]. Journal of Clinical Hepatology, 2013, 29(9): 674-677. doi: 10.3969/j.issn.1001-5256.2013.09.010
    [13]Wu XiaoQing, Wan Hong. Causes of liver failure and impact analysis of prognostic risk factors[J]. Journal of Clinical Hepatology, 2013, 29(4): 294-296+304.
    [14]Chen YongFang, Wu ZhanJun. Pathogenesis and risk factors of cholesterol gallstones in patients with non- alcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2013, 29(12): 952-955. doi: 10.3969/j.issn.1001-5256.2013.12.021
    [15]Wu Tao, Yin ShouYi, Wang HongZhang, Zhang Hong, Jia Wei, Ji Guang. The clinical features and risk factors of patient with metabolic syndrome combined with non-alcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2011, 27(10): 1036-1040.
    [16]Zhang YiNing, Du HongWei, Liu YanJun, Wang ChaoXia. The diagnosis and risk factors for evaluation of nonalcoholic fatty liver disease in children and adolescents[J]. Journal of Clinical Hepatology, 2011, 27(7): 690-693.
    [17]Wan Hong, Li Ling, Tang YanPing. study on fatty liver prevalence in the government officers in Lanzhou area[J]. Journal of Clinical Hepatology, 2008, 24(4): 261-262.
    [18]Wang Hong, Wang YingMin, Zhang Bo. Prospective analysis of risk factors for the occurrence of hepatocellular carcinoma in patients with post-hepatitis B cirrhosis[J]. Journal of Clinical Hepatology, 2007, 23(1): 34-35.
    [19]Wang Hong. Risk factors for patients with cirrhosis developed renal dysfunction[J]. Journal of Clinical Hepatology, 2004, 20(2): 101-102.
    [20]Chen MingWei, Yang MingGong, Wang YouMin, Wang ZhangJiang, Pan TianRong, Hu HongLin, Sun HaiYan. Risk factors analysis on nonalcoholic steatohepatitis in patients with type 2 diabetes[J]. Journal of Clinical Hepatology, 2004, 20(1): 44-45.
    • Supplements(0)
    • Cited By

  • Cited by

    Periodical cited type(1)

    1. 陈立中. 糖脂水平联合肝功能及血尿酸检测对老年脂肪肝的诊断效果. 系统医学. 2020(02): 43-45 .

    Other cited types(0)

  • 加载中
    Created with Highcharts 5.0.7Chart context menuAccess Class DistributionFULLTEXT: 3.3 %FULLTEXT: 3.3 %META: 92.5 %META: 92.5 %PDF: 4.3 %PDF: 4.3 %FULLTEXTMETAPDF
    Created with Highcharts 5.0.7Chart context menuAccess Area Distribution其他: 2.8 %其他: 2.8 %India: 0.3 %India: 0.3 %United States: 0.8 %United States: 0.8 %[]: 0.5 %[]: 0.5 %上海: 1.3 %上海: 1.3 %中卫: 0.3 %中卫: 0.3 %保定: 0.3 %保定: 0.3 %北京: 9.8 %北京: 9.8 %南宁: 0.3 %南宁: 0.3 %南昌: 0.3 %南昌: 0.3 %合肥: 0.5 %合肥: 0.5 %吉林: 1.0 %吉林: 1.0 %哥伦布: 0.3 %哥伦布: 0.3 %圣路易斯: 0.8 %圣路易斯: 0.8 %天津: 0.3 %天津: 0.3 %巴音郭楞: 0.3 %巴音郭楞: 0.3 %庆阳: 0.3 %庆阳: 0.3 %张家口: 2.8 %张家口: 2.8 %普洱: 0.3 %普洱: 0.3 %杭州: 0.5 %杭州: 0.5 %枣庄: 0.3 %枣庄: 0.3 %格兰特县: 0.3 %格兰特县: 0.3 %武汉: 1.0 %武汉: 1.0 %泰安: 0.3 %泰安: 0.3 %海口: 0.3 %海口: 0.3 %牡丹江: 0.3 %牡丹江: 0.3 %芒廷维尤: 36.9 %芒廷维尤: 36.9 %苏州: 0.3 %苏州: 0.3 %莫斯科: 1.8 %莫斯科: 1.8 %蚌埠: 0.3 %蚌埠: 0.3 %西宁: 32.9 %西宁: 32.9 %迈阿密: 0.5 %迈阿密: 0.5 %郑州: 0.3 %郑州: 0.3 %重庆: 0.5 %重庆: 0.5 %长春: 0.5 %长春: 0.5 %长沙: 0.5 %长沙: 0.5 %长治: 0.3 %长治: 0.3 %其他IndiaUnited States[]上海中卫保定北京南宁南昌合肥吉林哥伦布圣路易斯天津巴音郭楞庆阳张家口普洱杭州枣庄格兰特县武汉泰安海口牡丹江芒廷维尤苏州莫斯科蚌埠西宁迈阿密郑州重庆长春长沙长治

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索
    Get Citation
    PDF
    XML

    Article Metrics

    Article views (1619) PDF downloads(366) Cited by(1)
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[2183]YesterdayPV[4802]TodayIP[124]TodayPV[248]Online[14]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return